David Happel, President & CEO: Sagimet Biosciences SGMT Sell · Filed 25/07/23

Trade details

Type: Insider sale
Amount: $597,814.14
Shares · price: 65,478 sh · $9.13 a share
Held after: 689,722 sh
Stock: Sagimet Biosciences SGMT
Person: David HappelPresident & CEO
Trade date: 25/07/21
Filed: 25/07/23
Days to filing: 2 days

Sold 8.7% of holdings

Share of holding sold: 8.7%

Sagimet Biosciences trades, last 26 weeks

What else happened in Sagimet Biosciences around then

Filed or reported within 30 days of the trade day · 25/06/21~25/08/20

David Happel's recent trades

David HappelPresident & CEO
SellSagimet Biosciences
Sell
Sagimet Biosciences
SGMT
$64.9K
12,101 sh
$64.9K
Filed 02/12
Traded 02/10
David HappelPresident & CEO
BuySagimet Biosciences
Buy
Sagimet Biosciences
SGMT
$63.8K
12,100 sh
$63.8K
Filed 24/03/28
Traded 24/03/26
David HappelPresident & CEO
BuySagimet Biosciences
Buy
Sagimet Biosciences
SGMT
$6,560
1,600 sh
$6,560
Filed 23/12/08
Traded 23/12/07
David HappelPresident & CEO
BuySagimet Biosciences
Buy
Sagimet Biosciences
SGMT
$1,387
590 sh
$1,387
Filed 23/11/20
Traded 23/11/16